rs112033303

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 8P and 16B. PVS1BP6_Very_StrongBS1BS2

The NM_015697.9(COQ2):​c.64A>T​(p.Arg22*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0218 in 1,546,968 control chromosomes in the GnomAD database, including 428 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. R22R) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.018 ( 37 hom., cov: 32)
Exomes 𝑓: 0.022 ( 391 hom. )

Consequence

COQ2
NM_015697.9 stop_gained

Scores

6

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:1B:10

Conservation

PhyloP100: -3.50

Publications

21 publications found
Variant links:
Genes affected
COQ2 (HGNC:25223): (coenzyme Q2, polyprenyltransferase) This gene encodes an enzyme that functions in the final steps in the biosynthesis of CoQ (ubiquinone), a redox carrier in the mitochondrial respiratory chain and a lipid-soluble antioxidant. This enzyme, which is part of the coenzyme Q10 pathway, catalyzes the prenylation of parahydroxybenzoate with an all-trans polyprenyl group. Mutations in this gene cause coenzyme Q10 deficiency, a mitochondrial encephalomyopathy, and also COQ2 nephropathy, an inherited form of mitochondriopathy with primary renal involvement. [provided by RefSeq, Oct 2009]
COQ2 Gene-Disease associations (from GenCC):
  • coenzyme Q10 deficiency, primary, 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • mitochondrial disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • multiple system atrophy
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • Leigh syndrome with nephrotic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. There are 37 pathogenic variants in the truncated region.
BP6
Variant 4-83284851-T-A is Benign according to our data. Variant chr4-83284851-T-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 136978.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.018 (2736/152308) while in subpopulation NFE AF = 0.0257 (1748/68012). AF 95% confidence interval is 0.0247. There are 37 homozygotes in GnomAd4. There are 1312 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 37 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015697.9. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COQ2
NM_015697.9
c.64A>Tp.Arg22*
stop_gained
Exon 1 of 7NP_056512.5
COQ2
NM_001358921.2
MANE Select
c.-87A>T
upstream_gene
N/ANP_001345850.1Q96H96-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COQ2
ENST00000311469.9
TSL:1
c.64A>Tp.Arg22*
stop_gained
Exon 1 of 7ENSP00000310873.4Q96H96-4
COQ2
ENST00000647002.2
MANE Select
c.-87A>T
upstream_gene
N/AENSP00000495761.2Q96H96-1
COQ2
ENST00000311461.7
TSL:5
c.-87A>T
upstream_gene
N/AENSP00000311835.7Q96H96-3

Frequencies

GnomAD3 genomes
AF:
0.0180
AC:
2737
AN:
152194
Hom.:
37
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00504
Gnomad AMI
AF:
0.0285
Gnomad AMR
AF:
0.0174
Gnomad ASJ
AF:
0.0251
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00331
Gnomad FIN
AF:
0.0317
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0257
Gnomad OTH
AF:
0.0206
GnomAD2 exomes
AF:
0.0180
AC:
2785
AN:
154366
AF XY:
0.0176
show subpopulations
Gnomad AFR exome
AF:
0.00335
Gnomad AMR exome
AF:
0.0129
Gnomad ASJ exome
AF:
0.0311
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0300
Gnomad NFE exome
AF:
0.0262
Gnomad OTH exome
AF:
0.0199
GnomAD4 exome
AF:
0.0222
AC:
30922
AN:
1394660
Hom.:
391
Cov.:
33
AF XY:
0.0219
AC XY:
15087
AN XY:
689630
show subpopulations
African (AFR)
AF:
0.00451
AC:
142
AN:
31520
American (AMR)
AF:
0.0130
AC:
480
AN:
36856
Ashkenazi Jewish (ASJ)
AF:
0.0282
AC:
713
AN:
25290
East Asian (EAS)
AF:
0.0000279
AC:
1
AN:
35862
South Asian (SAS)
AF:
0.00341
AC:
270
AN:
79212
European-Finnish (FIN)
AF:
0.0289
AC:
1038
AN:
35976
Middle Eastern (MID)
AF:
0.0233
AC:
133
AN:
5714
European-Non Finnish (NFE)
AF:
0.0248
AC:
26939
AN:
1085784
Other (OTH)
AF:
0.0206
AC:
1206
AN:
58446
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
1737
3474
5211
6948
8685
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
980
1960
2940
3920
4900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0180
AC:
2736
AN:
152308
Hom.:
37
Cov.:
32
AF XY:
0.0176
AC XY:
1312
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.00503
AC:
209
AN:
41570
American (AMR)
AF:
0.0174
AC:
266
AN:
15314
Ashkenazi Jewish (ASJ)
AF:
0.0251
AC:
87
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00332
AC:
16
AN:
4824
European-Finnish (FIN)
AF:
0.0317
AC:
336
AN:
10614
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0257
AC:
1748
AN:
68012
Other (OTH)
AF:
0.0204
AC:
43
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
145
289
434
578
723
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0128
Hom.:
3
Bravo
AF:
0.0165
TwinsUK
AF:
0.0216
AC:
80
ALSPAC
AF:
0.0213
AC:
82
ESP6500AA
AF:
0.00418
AC:
16
ESP6500EA
AF:
0.0229
AC:
182
ExAC
AF:
0.0137
AC:
1530

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
4
not specified (4)
-
1
-
Coenzyme Q10 deficiency, primary, 1 (1)
-
-
1
Coenzyme Q10 deficiency, primary, 1;C3714927:Multiple system atrophy 1, susceptibility to (1)
-
-
1
Focal segmental glomerulosclerosis (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
0.44
DANN
Benign
0.96
Eigen
Benign
-0.94
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.0035
N
PhyloP100
-3.5
Vest4
0.26
GERP RS
-4.1
PromoterAI
0.11
Neutral
Mutation Taster
=164/36
disease causing (fs/PTC)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs112033303; hg19: chr4-84206004; COSMIC: COSV61022320; COSMIC: COSV61022320; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.